211 related articles for article (PubMed ID: 23877361)
1. Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations.
Kostaras X; Easaw JC
J Neurooncol; 2013 Oct; 115(1):1-8. PubMed ID: 23877361
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of high-dose chemotherapy and autologous stem cell transplantation in patients with relapsed medulloblastoma: a report on the Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 study.
Park JE; Kang J; Yoo KH; Sung KW; Koo HH; Lim DH; Shin HJ; Kang HJ; Park KD; Shin HY; Kim IH; Cho BK; Im HJ; Seo JJ; Park HJ; Park BK; Ahn HS
J Korean Med Sci; 2010 Aug; 25(8):1160-6. PubMed ID: 20676326
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Pérez-Martínez A; Lassaletta A; González-Vicent M; Sevilla J; Díaz MA; Madero L
J Neurooncol; 2005 Jan; 71(1):33-8. PubMed ID: 15719272
[TBL] [Abstract][Full Text] [Related]
4. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
5. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C
J Neurooncol; 1996 Jan; 27(1):87-98. PubMed ID: 8699230
[TBL] [Abstract][Full Text] [Related]
6. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
Sung KW; Lim DH; Son MH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ
Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
[TBL] [Abstract][Full Text] [Related]
7. Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol.
Adile AA; Kameda-Smith MM; Bakhshinyan D; Banfield L; Salim SK; Farrokhyar F; Fleming AJ
Syst Rev; 2020 Mar; 9(1):47. PubMed ID: 32127049
[TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.
Rieken S; Gaiser T; Mohr A; Welzel T; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
BMC Cancer; 2010 Aug; 10():450. PubMed ID: 20731859
[TBL] [Abstract][Full Text] [Related]
9. Proposed strategy for the use of high-dose chemotherapy with stem cell rescue and intrathecal topotecan without whole-brain irradiation for infantile classic medulloblastoma.
Yamada A; Moritake H; Kamimura S; Yamashita S; Takeshima H; Nunoi H
Pediatr Blood Cancer; 2014 Dec; 61(12):2316-8. PubMed ID: 25174961
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy.
Ridola V; Grill J; Doz F; Gentet JC; Frappaz D; Raquin MA; Habrand JL; Sainte-Rose C; Valteau-Couanet D; Kalifa C
Cancer; 2007 Jul; 110(1):156-63. PubMed ID: 17541945
[TBL] [Abstract][Full Text] [Related]
11. EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma.
Franceschi E; Hofer S; Brandes AA; Frappaz D; Kortmann RD; Bromberg J; Dangouloff-Ros V; Boddaert N; Hattingen E; Wiestler B; Clifford SC; Figarella-Branger D; Giangaspero F; Haberler C; Pietsch T; Pajtler KW; Pfister SM; Guzman R; Stummer W; Combs SE; Seidel C; Beier D; McCabe MG; Grotzer M; Laigle-Donadey F; Stücklin ASG; Idbaih A; Preusser M; van den Bent M; Weller M; Hau P
Lancet Oncol; 2019 Dec; 20(12):e715-e728. PubMed ID: 31797797
[TBL] [Abstract][Full Text] [Related]
12. Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study.
Hill RM; Richardson S; Schwalbe EC; Hicks D; Lindsey JC; Crosier S; Rafiee G; Grabovska Y; Wharton SB; Jacques TS; Michalski A; Joshi A; Pizer B; Williamson D; Bailey S; Clifford SC
Lancet Child Adolesc Health; 2020 Dec; 4(12):865-874. PubMed ID: 33222802
[TBL] [Abstract][Full Text] [Related]
13. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
Dunkel IJ; Gardner SL; Garvin JH; Goldman S; Shi W; Finlay JL
Neuro Oncol; 2010 Mar; 12(3):297-303. PubMed ID: 20167818
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Sung KW; Yoo KH; Cho EJ; Koo HH; Lim DH; Shin HJ; Ahn SD; Ra YS; Choi ES; Ghim TT
Pediatr Blood Cancer; 2007 Apr; 48(4):408-15. PubMed ID: 17066462
[TBL] [Abstract][Full Text] [Related]
15. Updates on Management of Adult Medulloblastoma.
Majd N; Penas-Prado M
Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
[TBL] [Abstract][Full Text] [Related]
16. Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors.
Gajjar A; Pizer B
Pediatr Blood Cancer; 2010 Apr; 54(4):649-51. PubMed ID: 20146223
[TBL] [Abstract][Full Text] [Related]
17. Relapse patterns in pediatric embryonal central nervous system tumors.
Perreault S; Lober RM; Carret AS; Zhang G; Hershon L; Décarie JC; Yeom K; Vogel H; Fisher PG; Partap S
J Neurooncol; 2013 Nov; 115(2):209-15. PubMed ID: 23921420
[TBL] [Abstract][Full Text] [Related]
18. Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.
Carrie C; Lasset C; Alapetite C; Haie-Meder C; Hoffstetter S; Demaille MC; Kerr C; Wagner JP; Lagrange JL; Maire JP
Cancer; 1994 Oct; 74(8):2352-60. PubMed ID: 7922986
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcomes of medulloblastoma in adults.
Ang C; Hauerstock D; Guiot MC; Kasymjanova G; Roberge D; Kavan P; Muanza T
Pediatr Blood Cancer; 2008 Nov; 51(5):603-7. PubMed ID: 18649371
[TBL] [Abstract][Full Text] [Related]
20. New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology.
Brandes AA; Bartolotti M; Marucci G; Ghimenton C; Agati R; Fioravanti A; Mascarin M; Volpin L; Ammannati F; Masotto B; Gardiman MP; De Biase D; Tallini G; Crisi G; Bartolini S; Franceschi E
Crit Rev Oncol Hematol; 2015 Jun; 94(3):348-59. PubMed ID: 25600839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
